TY - JOUR
T1 - Assessment of the control measures of the category A diseases of Animal Health Law
T2 - Burkholderia mallei (Glanders)
AU - Nielsen, Søren Saxmose
AU - Alvarez, Julio
AU - Bicout, Dominique Joseph
AU - Calistri, Paolo
AU - Canali, Elisabetta
AU - Drewe, Julian Ashley
AU - Garin-Bastuji, Bruno
AU - Gonzales Rojas, José Luis
AU - Schmidt, Christian Gortázar
AU - Herskin, Mette
AU - Michel, Virginie
AU - Miranda Chueca, Miguel Ángel
AU - Padalino, Barbara
AU - Pasquali, Paolo
AU - Spoolder, Hans
AU - Ståhl, Karl
AU - Velarde, Antonio
AU - Viltrop, Arvo
AU - Winckler, Christoph
AU - Gubbins, Simon
AU - Laroucau, Karine
AU - Antoniou, Sotiria-Eleni
AU - Aznar, Inma
AU - Broglia, Alessandro
AU - Lima, Eliana
AU - Van der Stede, Yves
AU - Zancanaro, Gabriele
AU - Roberts, Helen Clare
AU - EFSA Panel on Animal Health and Welfare (AHAW)
PY - 2022/1
Y1 - 2022/1
N2 - EFSA received a mandate from the European Commission to assess the effectiveness of some of the control measures against diseases included in the Category A list according to Regulation (EU) 2016/429 on transmissible animal diseases ('Animal Health Law'). This opinion belongs to a series of opinions where these control measures will be assessed, with this opinion covering the assessment of control measures for glanders. In this opinion, EFSA and the AHAW Panel of experts review the effectiveness of: (i) clinical and laboratory sampling procedures, (ii) monitoring period and (iii) the minimum radius of the protection and surveillance zone, and the minimum length of time the measures should be applied in these zones. The general methodology used for this series of opinions has been published elsewhere. Considering the epidemiology and distribution of glanders, it was foreseen that three different situations could lead to a suspicion of the disease. Sampling procedures were defined for each of the three different suspicion types, which can also be applied in most of the other scenarios assessed. The monitoring period (6 months) was assessed as effective in all scenarios. The AHAW Panel of experts considered the minimum radius and duration of the existing protection and surveillance zone, set at the establishment level, effective. Recommendations provided for each of the scenarios assessed aim to support the European Commission in the drafting of further pieces of legislation, as well as for plausible ad hoc requests in relation to glanders.
AB - EFSA received a mandate from the European Commission to assess the effectiveness of some of the control measures against diseases included in the Category A list according to Regulation (EU) 2016/429 on transmissible animal diseases ('Animal Health Law'). This opinion belongs to a series of opinions where these control measures will be assessed, with this opinion covering the assessment of control measures for glanders. In this opinion, EFSA and the AHAW Panel of experts review the effectiveness of: (i) clinical and laboratory sampling procedures, (ii) monitoring period and (iii) the minimum radius of the protection and surveillance zone, and the minimum length of time the measures should be applied in these zones. The general methodology used for this series of opinions has been published elsewhere. Considering the epidemiology and distribution of glanders, it was foreseen that three different situations could lead to a suspicion of the disease. Sampling procedures were defined for each of the three different suspicion types, which can also be applied in most of the other scenarios assessed. The monitoring period (6 months) was assessed as effective in all scenarios. The AHAW Panel of experts considered the minimum radius and duration of the existing protection and surveillance zone, set at the establishment level, effective. Recommendations provided for each of the scenarios assessed aim to support the European Commission in the drafting of further pieces of legislation, as well as for plausible ad hoc requests in relation to glanders.
KW - Burkholderia mallei
KW - disease control measures
KW - glanders
KW - monitoring period
KW - protection zone
KW - sampling procedures
KW - surveillance zone
UR - http://www.scopus.com/inward/record.url?scp=85125296284&partnerID=8YFLogxK
U2 - 10.2903/j.efsa.2022.7069
DO - 10.2903/j.efsa.2022.7069
M3 - Journal article
C2 - 35035583
SN - 1831-4732
VL - 20
JO - EFSA Journal
JF - EFSA Journal
IS - 1
M1 - e07069
ER -